Patents Represented by Attorney B. Coregory Donner
  • Patent number: 6946446
    Abstract: The invention relates to novel methods for using macrolide anti-infective agents. The macrolide anti-infective agents demonstrate antibacterial activity against multi-drug resistant strains of bacteria and, in particular, methicillin-resistant Staphylococcus aureus (MRSA). Methods for inhibiting the activity of multi-drug resistant bacterial organisms and methods for treating a bacterial infection caused by such organisms are described herein.
    Type: Grant
    Filed: February 23, 2001
    Date of Patent: September 20, 2005
    Assignee: Abbott Laboratories
    Inventors: Zhenkun Ma, Peter Nemoto, Suoming Zhang, Hong Yong, Yat Sun Or
  • Patent number: 6818654
    Abstract: Antibacterials having formula (I) and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates used in the processes, compositions containing the compounds, and methods of prophylaxis and treatment of bacterial infections using the compounds are disclosed.
    Type: Grant
    Filed: March 12, 2003
    Date of Patent: November 16, 2004
    Assignee: Abbott Laboratories
    Inventors: David Anderson, Bruce Beutel, Curt Cooper, Peter Dandliker, Caroline David, Yu-Gui Gu, Mira Hinman, Douglas Kalvin, Linda Lynch, Zhenkun Ma, Christopher Motter, Teresa Rosenberg, William Sanders, Michael Tufano, Rolf Wagner, Moshe Weitzberg, Hong Yong
  • Patent number: 6667338
    Abstract: Compounds of formula (I) and formula (II) or therapeutically acceptable salts or prodrugs thereof are useful as antibacterial agents. Methods to make the compounds, compositions containing the compounds, and methods of treatment using the compounds are also disclosed.
    Type: Grant
    Filed: January 16, 2002
    Date of Patent: December 23, 2003
    Assignee: Abbott Laboratories
    Inventors: Zhenkun Ma, Ly Tam Phan, Suoming Zhang, Stevan W. Djuric
  • Patent number: 6593314
    Abstract: The present invention provides compounds of formula Ia and Ib or a pharmaceutically acceptable salt, prodrug, or ester thereof, useful in the inhibition of neuraminidase enzymes from disease-causing microorganisms, especially influenza neuraminidase, pharmaceutical formulations containing same, processes and intermediates for preparing said compounds, as well as methods of using said compounds, including preventing and treating diseases caused by microorganisms having said neuraminidase enzyme.
    Type: Grant
    Filed: September 22, 2000
    Date of Patent: July 15, 2003
    Assignee: Abbott Laboratories
    Inventors: Clarence J. Maring, Vincent L. Giranda, Yu Gui Gu, Stephen Hanessian, Dale J. Kempf, Darold L. Madigan, Kent Stewart, Vincent S. Stoll, Minghua Sun, Gary T. Wang, Jianchio Wang, Chen Zhao
  • Patent number: 6569836
    Abstract: The present invention relates to 6-O-alkyl-2-nor-2-substituted ketolide compound or a derivative thereof, a composition comprising the compound and a suitable carrier, a method of preparing the compound, and a method of treatment and prevention of in mammals comprising administering said compound.
    Type: Grant
    Filed: November 30, 2000
    Date of Patent: May 27, 2003
    Assignee: Abbott Laboratories
    Inventors: Ly Tam Phan, Yat Sun Or, Zhenkun Ma